| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.7 | $5k-$25k | 0.00 |
Summary
A vulnerability was found in IBM Business Automation Workflow and Business Process Manager. It has been classified as critical. This vulnerability affects unknown code. Performing a manipulation results in privileges management. This vulnerability is known as CVE-2020-4490. Remote exploitation of the attack is possible. No exploit is available.
Details
A vulnerability was found in IBM Business Automation Workflow and Business Process Manager (Business Process Management Software) (unknown version). It has been classified as critical. This affects an unknown code block. The manipulation with an unknown input leads to a privileges management vulnerability. CWE is classifying the issue as CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:
IBM Business Automation Workflow 18 and 19, and IBM Business Process Manager 8.0, 8.5, and 8.6 could allow a remote attacker to bypass security restrictions, caused by a reverse tabnabbing flaw. An attacker could exploit this vulnerability and redirect a vitcim to a phishing site. IBM X-Force ID: 181989
The weakness was published 05/29/2020 (Website). It is possible to read the advisory at exchange.xforce.ibmcloud.com. This vulnerability is uniquely identified as CVE-2020-4490 since 12/30/2019. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. The technical details are unknown and an exploit is not publicly available. The pricing for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 05/30/2020). It is expected to see the exploit prices for this product increasing in the near future.The attack technique deployed by this issue is T1068 according to MITRE ATT&CK.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Be aware that VulDB is the high quality source for vulnerability data.
Product
Type
Vendor
Name
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.7VulDB Meta Temp Score: 6.7
VulDB Base Score: 7.3
VulDB Temp Score: 7.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 6.1
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Privileges managementCWE: CWE-269 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
12/30/2019 🔍05/29/2020 🔍
05/30/2020 🔍
10/21/2020 🔍
Sources
Vendor: ibm.comAdvisory: exchange.xforce.ibmcloud.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2020-4490 (🔍)
GCVE (CVE): GCVE-0-2020-4490
GCVE (VulDB): GCVE-100-155895
X-Force: 181989
Entry
Created: 05/30/2020 11:10Updated: 10/21/2020 07:55
Changes: 05/30/2020 11:10 (37), 05/30/2020 11:15 (18), 10/21/2020 07:51 (1), 10/21/2020 07:55 (1)
Complete: 🔍
Cache ID: 216::103
Be aware that VulDB is the high quality source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.